AZA-RUX

Sankalp Arora: Excited to be presenting longterm follow up results of AZA + RUX in patients with myelofibrosis at ASCO24

Sankalp Arora, Heme/Onc fellow at MD Anderson Cancer Center, shared on X/Twitter:

“The ASCO24 countdown begins!
Excited to be presenting longterm follow up results of phase 2 clinical trial at MD Anderson Cancer Center evaluating AZA + RUX combination therapy in patients with myelofibrosis.

Link to abstract.”

Source: Sankalp Arora/X

and Tapan Kadia ASCO24 AZA + RUX cancer combination therapy Hagop Kantarjian longterm follow up MD Anderson Cancer Center myelofibrosis Naveen Pemmaraju OncoDaily Oncology phase 2 clinical trial Prithviraj Bose Sankalp Arora